NCT06863311
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06863311
Title Trial of XL092 in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC (EXACT)
Acronym EXACT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karie Runcie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.